LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes
عنوان الدراسة
LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes
داعم الدراسة
Novartis
دواء الدراسة
RANIBIZUMAB
رقم بروتوكول الدراسة
RFB002A240
حالة الدراسة
Ongoing
موقع الدراسة
king khaled eye specialist hospital (riyadh)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。